If regulatory submissions proceed as expected, the earliest plausible timeline for a market authorisation decision in the UK or Europe would be 2026 or 2027 though this is subject to the pace of regulatory review, the completeness of the submission package, and any additional data requests from the MHRA or EMA
Glutathione has been utilized in the treatment of various conditions such as Parkinson's disease, Alzheimer's disease, cancer, and HIV/AIDS
In specific exposure phenotypes including BS-COPD, chronopharmacology broadens the intervention window
2024).Furthermore, Spirulina aqueous extracts are known to include twelve peptides which enhance aortic vascular activity leading to attenuated superoxide generation, enhanced heme oxygenase-1 and phosphorylated eNOS levels, and nitric oxide release (Prete et al
The inclusion of TB-500 and GHK-Cu further supports investigation into peptide interaction dynamics, extracellular matrix-associated processes, and coordinated signaling behavior within laboratory research systems